Vasoactive Intestinal Peptide Secreting Tumors. Pathophysiological and Clinical Correlations
- 1 June 1988
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 527 (1), 518-527
- https://doi.org/10.1111/j.1749-6632.1988.tb27005.x
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Effect of peptide histidine isoleucine on water and electrolyte transport in the human jejunum.Gut, 1984
- Peptide histidine isoleucine: a secretagogue in human jejunum.Gut, 1984
- DIARRHOEA IN VIPOMA PATIENTS ASSOCIATED WITH COSECRETION OF A SECOND ACTIVE PEPTIDE (PEPTIDE HISTIDINE ISOLEUCINE) EXPLAINED BY SINGLE CODING GENEThe Lancet, 1983
- Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27Nature, 1983
- ARE PEPTIDE HISTIDINE ISOLEUCINE AND VASOACTIVE INTESTINAL PEPTIDE CO-SYNTHESISED IN THE SAME PRO-HORMONE?The Lancet, 1982
- Isolation and characterization of the intestinal peptide porcine PHI (PHI-27), a new member of the glucagon--secretin family.Proceedings of the National Academy of Sciences, 1981
- Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas).BMJ, 1981
- VASOACTIVE INTESTINAL PEPTIDE AND WATERY-DIARRHŒA SYNDROMEThe Lancet, 1973
- Polypeptide with Broad Biological Activity: Isolation from Small IntestineScience, 1970
- Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemiaThe American Journal of Medicine, 1958